ARK ETF Trust - ARK Genomic Revolution ETF (LON:0CQL)
53.02
+1.32 (2.55%)
At close: Sep 22, 2026
LON:0CQL Holdings Information
LON:0CQL is an equity ETF with a total of 33 individual holdings. The top holdings are 10x Genomics stock at 9.46%, Tempus AI at 9.23%, Twist Bioscience at 9.00%, CRISPR Therapeutics AG at 5.72%, and Personalis at 5.13%.
Total Holdings
33
Top 10 Percentage
60.41%
Asset Class
Equity
ETF Category
Theme
Assets
1.65B
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TXG | 10x Genomics, Inc. | 9.46% |
| 2 | TEM | Tempus AI, Inc. | 9.23% |
| 3 | TWST | Twist Bioscience Corporation | 9.00% |
| 4 | CRSP | CRISPR Therapeutics AG | 5.72% |
| 5 | PSNL | Personalis, Inc. | 5.13% |
| 6 | GH | Guardant Health, Inc. | 4.99% |
| 7 | ABSI | Absci Corporation | 4.59% |
| 8 | ILMN | Illumina, Inc. | 4.24% |
| 9 | NTRA | Natera, Inc. | 4.23% |
| 10 | CDNA | CareDx, Inc. | 3.82% |
| 11 | LLY | Eli Lilly and Company | 3.52% |
| 12 | CMPS | COMPASS Pathways plc | 3.22% |
| 13 | SDGR | Schrödinger, Inc. | 3.18% |
| 14 | BEAM | Beam Therapeutics Inc. | 2.91% |
| 15 | WGS | GeneDx Holdings Corp. | 2.53% |
| 16 | ADPT | Adaptive Biotechnologies Corporation | 2.44% |
| 17 | RXRX | Recursion Pharmaceuticals, Inc. | 2.32% |
| 18 | ARCT | Arcturus Therapeutics Holdings Inc. | 2.23% |
| 19 | NRIX | Nurix Therapeutics, Inc. | 2.06% |
| 20 | BFLY | Butterfly Network, Inc. | 1.83% |
| 21 | VCYT | Veracyte, Inc. | 1.80% |
| 22 | IONS | Ionis Pharmaceuticals, Inc. | 1.69% |
| 23 | NTLA | Intellia Therapeutics, Inc. | 1.51% |
| 24 | ALMR | Alamar Biosciences, Inc. | 1.47% |
| 25 | GENB | Generate Biomedicines, Inc. | 1.26% |
As of Sep 18, 2026